Showing results (211-220 of 969) with videos related to
Sort By:
Pageof 97
Expert Review of Clinical Immunology|June 22, 2016
Current status and future prospects for biologic treatments of psoriasisAbigail Cline, Dane Hill, Robin Lewallen, et al.Expert Opinion on Drug Metabolism & Toxicology|September 11, 2023
JAK1 inhibitors for the treatment of atopic dermatitis: a focus on pharmacokinetic considerationsHannah Kopelman, Christina Kontzias, Christopher Alihosseni, et al.Journal of Drugs in Dermatology : JDD|October 6, 2023
Cidofovir in the Management of Non-Genital Warts: A ReviewMadison K Cook, Erin M Hagen, Steven R FeldmanJournal of the American Academy of Dermatology|July 26, 2002
Off-label prescribing in the treatment of dermatologic diseaseJoel H Sugarman, Alan B Fleischer, Steven R FeldmanThe Journal of Dermatological Treatment|October 28, 2022
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasisRachel C Ruda, Katherine A Kelly, Steven R FeldmanSeminars in Cutaneous Medicine and Surgery|May 20, 2005
The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis careKevin R Stein, Daniel J Pearce, Steven R FeldmanExpert Opinion on Pharmacotherapy|June 4, 2021
An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acneVeronica K Emmerich, Caitlin G Purvis, Steven R FeldmanThe Journal of Clinical and Aesthetic Dermatology|July 5, 2022
Infrequent Follow-Up for Actinic Keratosis Treatment: A National Ambulatory Medical Care SurveyRohan Singh, Ayman Grada, Alan Fleischer, et al.Dermatology Online Journal|June 13, 2021
The effect of physician appearance on patient perceptions of treatment plansJeremy K Bray, Caroline L Porter, Steven R FeldmanThe Journal of Dermatological Treatment|October 16, 2007
Targeted UV therapy in the treatment of psoriasisKevin R Stein, Daniel J Pearce, Steven R FeldmanPageof 97